Endogenous hematopoietic reconstitution induced by human umbilical cord blood cells in immunocompromised mice: Implications for adoptive therapy

Experimental Hematology

Volumn 27, Issue 1, 1999, Pages 176-185

  Rameshwar, Pranela ^a   Smith, Indra ^a   Ende, Norman ^a,b   Batarseh, Hani E ^a   Ponzio, Nicholas M ^a,b  

^a RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MEDICINE AND DENTISTRY OF NEW JERSEY   (United States)

Author keywords

Bone marrow transplantation; Hematopoiesis; Irradiation; Stem cell; Umbilical cord blood

Indexed keywords

ADOPTIVE IMMUNOTHERAPY; ANIMAL EXPERIMENT; ARTICLE; COLONY FORMING UNIT GM; CONTROLLED STUDY; FEMALE; HEMATOPOIESIS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; IMMUNE DEFICIENCY; IRRADIATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; UMBILICAL CORD BLOOD;

ADJUVANTS, IMMUNOLOGIC; ADOPTIVE TRANSFER; ANIMALS; BONE MARROW CELLS; CELL MOVEMENT; CELLS, CULTURED; DOSE-RESPONSE RELATIONSHIP, RADIATION; FEMALE; FETAL BLOOD; GAMMA RAYS; HEMATOPOIESIS; HUMANS; IMMUNOCOMPROMISED HOST; IMMUNOPHENOTYPING; INFANT, NEWBORN; LEUKOCYTES, MONONUCLEAR; LYMPHOCYTES; LYMPHOID TISSUE; MICE; RECOVERY OF FUNCTION; TIME FACTORS; WHOLE-BODY IRRADIATION;

ANIMALIA;

EID: 0032975262     PISSN: 0301472X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0301-472X(98)00008-3     Document Type: Article

References (42)

1. Shizuru J.A., Jerabek L., Edwards C.T., Weissman I.L. Transplantation of purified hematopoietic stem cells. requirements for overcoming the barriers of allogeneic engraftment Biol Blood Marrow Transpl. 2:1996;3.
2. Martin P.J., Hansen J.A., Buckner C.D., Sanders J.E., Deeg H.J., Stewart P., Appelbaum F.R., Clift R., Fefer A., Witherspoon R.P., Kennedy M.S., Sullivan K.M., Flournoy N., Storb R., Thomas E.D. Effects of in vitro depletion of T cells in HLA-identical allogeneic marrow grafts. Blood. 66:1985;664.
3. Apperley J.F. Umbilical cord blood progenitor cell transplantation. Bone Marrow Transplant. 14:1994;187.
4. Hao Q.-L., Shah A.J., Thiemann F.T., Smogorzewska E.M., Crooks G.M. A functional comparison of CD34+ CD38- cells in cord blood and bone marrow. Blood. 86:1995;3745.
5. Kohli-Kumar M., Shahidi N.T., Broxmeyer H.E., Masterson M., Delaat C., Sambrano J., Morris C., Auerbach A.D., Harris R.E. Hematopoietic stem/progenitor cell transplant in Fanconi anemia using HLA-matched sibling umbilical cord blood cells. Br J Haematol. 85:1993;419.
6. Pahwa R.N., Fleischer A., Than S., Good R.A. Successful hematopoietic reconstitution with transplantation of erythroid-depleted allogeneic human umbilical cord blood cells in a child with leukemia. Proc Natl Acad Sci USA. 91:1994;4485.
7. Broxmeyer H.E., Gluckman E., Auerbach A.D., Douglas G.W., Friedman H., Cooper S., Hangoc G., Kurtzberg J., Bard J., Boyse E.A. Human umbilical cord blood. a clinically useful source of transplantable hematopoietic stem/progenitor cells Intl J Cell Cloning. 1:1990;76.
8. De La Selle V., Gluckman E., Bruley-Rosset M. Newborn blood can engraft adult mice without inducing graft-versus-host disease across non H-2 antigens. Blood. 87:1996;3977.
9. Miniero R., Busca A., Roncarolo M.G., Saitta M., Iavarone A., Timeus F., Biondi A., Amoroso A., Perugini L., Ciuti E., Saracco P., Ruggieri L., Vassallo E., Gabutti HLA-haploidentical umbilical cord blood stem cell transplantation in a child with advanced leukemia. clinical outcome and analysis of hematopoietic recovery Bone Marrow Transplant. 16:1995;229.
10. Harris D.T., Schumacher M.J., Locascio J., Besencon F.J., Olson G.B., DeLuca D., Schenker L., Bard J., Boyse E.A. Phenotypic and functional immaturity of human umbilical cord blood T lymphocytes. Proc Natl Acad Sci USA. 89:1992;10006.
11. Takahashi N., Imanishi K., Nishida H., Uchiyama T. Evidence for immunologic immaturity of cord blood T cells. Cord blood T cells are susceptible to tolerance induction to in vitro stimulation with a superantigen. J Immunol. 155:1995;5213.
12. Taylor S., Bryson Y.J. Impaired production of γ-interferon by newborn cells in vitro is due to a functionally immature macrophage. J Immunol. 134:1985;1493.
13. Tucci A., Mouzaki A., James H., Bonnefoy J.-Y., Zubler R.H. Are cord blood B cells functionally mature? Clin Exp Immunol. 84:1991;389.
14. Hunt D.W.C., Huppertz H.-I., Jiang H.-J., Petty R.E. Studies of human cord blood dendritic cells. evidence for functional immaturity Blood. 84:1994;4333.
15. Alford C.A., Britt W.J. Cytomegalovirus. Fields B.H., Knipe D.M. Virology. 1990;Raven Press, New York. 1981p.
16. Ho M., Jaffe R., Miller G., Breinig M.K., Dummer J.S., Makowka L., Atchison R.W., Karrer F., Nalesnik M.A., Starzl T.E. The frequency of Epstein-Barr virus infection and associated lymphoproliferative syndrome after transplantation and its manifestations in children. Transplantation. 45:1988;719.
17. Wagner J.E., Kernan N.A., Steinbuch M., Broxmeyer H.E., Gluckman E. Allogeneic sibling umbilical-cord blood transplantation in children with malignant and non-malignant disease. Lancet. 346:1995;214.
18. Ende N., Ponzio N.M., Athwal R.S., Ende M., Giuliani D.C. Murine survival of lethal irradiation with the use of human umbilical cord blood. Life Sci. 51:1992;1249.
19. Ende N., Ponzio N.M., Giuliani D., Bagga P.S., Godyn J. The effect of human cord blood on SJL/J mice after chemoablation and irradiation and its possible clinical significance. Immunol Invest. 24:1995;999.
20. Ponzio N.M., Zhang D.J., Tsiagbe V.K., Thorbecke G.J. Influence of the Mtv superantigen on B cell lymphoma development in SLJ/J mice. Tomonari K. Viral superantigens. 1997;CRC Press Inc, Boca Raton, FL. 219p.
21. Lin T.-Z., Ponzio N.M. Syngeneic B lymphoma cells provide a unique stimulus to natural killer (NK) cells in genetically low-NK SJL/J mice. J Leukoc Biol. 49:1991;48.
22. Rameshwar P., Ganea D., Gascón P. In vitro stimulatory effect of substance P on hematopoiesis. Blood. 81:1993;391.
23. Lerner C., Harrison D.E. 5-fluorouracil spares hemopoietic stem cells responsible for long-term repopulation. Exp Hematol. 18:1990;114.
24. Ende N., Giuliani D., Ende M., Ponzio N.M. Production of human to mouse xenografts by umbilical cord blood. Life Sci. 46:1990;1373.
25. Almici C., Carlo-Stella C., Mangoni L., Garau D., Cottafavi L., Ventura A., Armanetti M., Wagner J.E., Rizzoli V. Density separation of umbilical cord blood and recovery of hemopoietic progenitor cells. implications for cord blood banking Stem Cells. 13:1995;533.
26. Hamood M., Corazza F., Bujan-Boza W., Sariban E., Fondu P. Natural killer (NK) cells inhibit human umbilical cord blood erythropoiesis. Exp Hematol. 23:1995;1187.
27. Afifi M., Kumar V., Bennett M. Stimulation of genetic resistance to marrow grafts in mice by IFN-α/β J Immunol. 134:1985;3739.
28. Davenport C., Kumar V., Bennett M. Use of newborn liver cells as a murine model for cord blood cell transplantation. J Immunol. 151:1993;1597.
29. Tsiagbe V.K., Yoshimoto T., Asakawa J., Cho S.Y., Meruelo D., Thorbecke G.J. Linkage of superantigen-like stimulation of syngeneic T cells in a mouse model of follicular center B cell lymphoma to transcription of endogenous mammary tumor virus. EMBO J. 12:1993;2313.
30. Tsiagbe V.K., Asakawa J., Miranda A., Sutherland R.M., Paterson Y., Thorbecke G.J. Syngeneic response to SJL follicular center B cell lymphoma (reticular cell sarcoma) cells is primarily in Vβ16+ CD4+ T cells. J Immunol. 150:1993;5519.
31. Neipp M., Zorine T., Ildstad S.T. Kinetics of mobilization and repopulation potential of facilitating cells and hematopoietic stem cells mobilized by FLT3 and G-CSF. Blood. 90:1997;360a.
32. Ildstad S.T., Crilley P.A., Shadduck R.K., Kaufman C.L., Mirro J., Brodsky I., Brugger W., Gajewski J.L., Przepiorka D., Styler M.J., Lister J., Topolsky D.L., Manz M., Kanz L., Ghamplin R.L. Graft engineering. the facilitating cell protocol in HLA mismatched BMT for hematologic malignancy Blood. 90:1997;111a.
33. Traycoff C.M., Abboud M.R., Laver J., Brandt J.E., Hoffman R., Law P., Ishizawa L., Srour E.F. Evaluation of the in vitro behavior of phenotypically defined populations of umbilical cord blood hematopoietic progenitor cells. Exp Hematol. 22:1994;215.
34. Deeg H.J., Seidel K., Yu C., Nash R., Huss R., Schuening F., Storb R. Delay of radiation-induced decline and recovery of hematopoiesis following treatment with anti-HLA-DR antibody. Biol Blood Marrow Transplant. 2:1996;105.
35. LeBien T.W., McCormack R.T. The common acute lymphoblastic leukemia antigen (CD10)-emancipation from a functional enigma. Blood. 73:1989;625.
36. Stimler-Gerard N.P. Neutral endopeptidase-like enzyme controls the contractile activity of substance P in guinea pig lung. J Clin Invest. 79:1987;1819.
37. Rameshwar P., Poddar A., Gascón P. Hematopoietic regulation mediated by interactions among the neurokinins and cytokines. Leuk Lymphoma. 28:1997;1.
38. Sautois B., Fillet G., Beguin Y. Comparative cytokine production by in vitro stimulated mononucleated cells from cord blood and adult blood. Exp Hematol. 25:1997;103.
39. Hoffman R., Szilvassy S.J. Enriched hematopoietic stem cells. basic biology and clinical utility Biol Blood Marrow Transpl. 1:1995;3.
40. Veronck L.F., Dekker A.W., de Gast G.C., van Kempen M.L., Lokhorst H.M., Nieuwenhuis H.K. Allogeneic bone marrow transplantation with a fixed low number of T cells in the marrow graft. Blood. 83:1994;3090.
41. Mitsuyasu R.T., Champlin R.E., Gale R.P., Ho W.G., Lenarsky C., Winston D., Selch M., Elashoff R., Giorgi J.V., Wells J., Terasaki P., Billing R., Feig S. Treatment of donor bone marrow with monoclonal anti-T cell antibody and complement for the prevention of graft-versus-host disease. Ann Intern Med. 105:1986;20.
42. Wagner J.E. Unbilical cord blood stem cell transplantation. Am J Ped Hematol/Oncol. 15:1993;169.